Pre-screening for Metabolic and Psychiatric Health Studies

This study, called DOVE-MET-COME-100, is looking for adults aged 18 and over to see if they might be a good fit for future clinical trials focused on metabolic conditions (like obesity, prediabetes, and heart disease) and mental health disorders. It's an observational study, meaning you won't receive any new treatments. You'll be asked about your health history and may have blood work (to check things like A1c for diabetes, cholesterol, and liver/kidney function) and other basic health checks. A doctor will review your information to see if you could be eligible for upcoming research. The main goal is to see how many people are interested in participating in future industry-sponsored clinical research over five years. We don't know the current enrollment status.

Study design
This is an observational study designed to identify potential participants for future clinical trials. It aims to enroll 7000 participants.
What's involved
You would provide informed consent, complete surveys about your health, and may have vital signs, urine drug tests, blood samples, and pregnancy tests collected. A physician will also conduct a one-on-one interview to review your medical history.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, which measures interest in future research, is assessed at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07106879

Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

Recruiting
Not specifiedAges 18+Observational
Clindove Research LLC
~7,000 participants
Updated 2025-08-12 on ClinicalTrials.gov
What's tested:Blood Work

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants who express interest in industry-sponsored clinical research
Measured over 5 years
Cardiovascular Diseases
Metabolic Syndrome
Obesity
Prediabetes
Mental Health Disorders
Endocrine Dysfunction
Type 2 Diabetes Mellitus (T2DM)
Chronic Kidney Disease (CKD)
1 sites across 1 states
New York1
  • Nelly Cohen, MD · PRINCIPAL_INVESTIGATOR · Clindove Research LLC

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any participant of age 18 years and over
Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures.

Exclusion

Pregnant or breastfeeding individuals
Individuals having severe cognitive impairment or inability to provide informed consent
Individuals having acute psychiatric emergencies requiring immediate intervention/hospitalization
Individuals who are currently participating in another research study that conflicts with pre-screening data collection
Individuals having known history of drug/alcohol misuse
Individuals having medical conditions that, in the investigator's opinion, could compromise the integrity of the screening process or pose significant risks to the participant's health.
  • Number of participants who express interest in industry-sponsored clinical research5 years

    The number of participants who express interest in industry-sponsored clinical research in each of the following therapeutic areas: cardiovascular, endocrine, metabolic and mental health disorder.